References
- Beasley RJ, Lai CK, Pearce N. Prevalence and etiology of asthma. J Allergy Clin Immunol 2000;105:466–472.
- Bochner BS, Busse WW. Allergy and asthma. J Allergy Clin Immunol 2005;115:953–959.
- Kim HJ, Park GM, Kim JK. Anti-inflammatory effect of pristimerin on lipopolysaccharide-induced inflammatory responses in murine macrophages. Arch Pharm Res 2013;36:495–500.
- Vervoordeldonk MJBM, Tak PP. Cytokines in rheumatoid arthritis. Curr Rheumatol Rep 2002;4:208–217.
- Tong L, Nanjundaiah SM, Venkatesha SH, et al. Pristimerin, a naturally occurring triterpenoid, protects against autoimmune arthritis by modulating the cellular and soluble immune mediators of inflammation and tissue damage. Clin Immunol 2014;155:220–230.
- Deeb D, Gao X, Liu YB, et al. Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NF-κB/mTOR signaling proteins and anti-apoptotic BCl-2. Int J Oncol 2014;44:1707–1715.
- Yang H, Landis‐Piwowar KR, Lu D, et al. Pristimerin induces apoptosis by targeting the proteasome in prostate cancer cells. J Cell Biochem 2008;103:234–244.
- Tiedemann RE, Schmidt J, Keats JJ, et al. Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-kappaB with antimyeloma activity in vitro and in vivo. Blood 2009;113:4027–4037.
- Figueiredo JN, Räz B, Séquin U. Novel quinone methides from Salacia kraussii with in vitro antimalarial activity. J Nat Prod 1998;61:718–723.
- Jeller AH, Silva DHS, Lião LM, et al. Antioxidant phenolic and quinonemethide triterpenes from Cheiloclinium cognatum. Phytochemistry 2004;65:1977–1982.
- Robinson D, Hamid Q, Bentley A, et al. Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopicasthma. J Allergy Clin Immunol 1993;92:313–324.
- Renz H, Smith HR, Henson JE, et al. Aerosolized antigen exposure without adjuvant causes increased IgE production and increased airway responsiveness in the mouse. J Allergy Clin Immunol 1992;89:1127–1138.
- Vojdani A, Erde J. Regulatory T cells, a potent immunoregulatory target for CAM researchers: modulating tumor immunity, autoimmunity and alloreactive immunity (III). Evid Based Compl Altern 2006;3:309–316.
- Fish SC, Donaldson DD, Goldman SJ, et al. IgE generation and mast cell effector function in mice deficient in IL-4 and IL-13. J Immunol 2005;174:7716–7724.
- Kouro T, Takatsu K. IL-5- and eosinophil-mediated inflammation: from discovery to therapy. Int Immunol 2009;21:1303–1309.
- Patricia C, Fulkerson C. Eosinophils and CCR3 regulate interleukin-13 transgene-induced pulmonary remodeling. Am J Pathol 2006;169:2117–2126.
- Wakahara K, Tanaka H, Takahashi G, et al. Repeated instillations of Dermatophagoides farinae into the airways can induce Th2-dependent airway hyperresponsiveness, eosinophili and remodeling in mice: effect of intratracheal treatment of uticasone propionate. Eur J Pharmacol 2008;578:87–96.
- Lee YN, Tuckerman J, Nechushtan H, et al. c-Fos as a regulator of degranulation and cytokine production in FcepsilonRI-activated mast cells. J Immunol 2004;173:2571–2577.
- Maneechotesuwan K, Xin Y, Ito K, et al. Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3. J Immunol 2007;178:2491–2498.
- Kim DY, Park JW, Jeoung D, Ro JY. Celastrol suppresses allergen-induced airway inflammation in a mouse allergic asthma model. Eur J Pharmacol 2009;612:98–105.
- Marok R, Winyard PG, Coumbe A, et al. Activation of the transcription factor nuclear factor-kappaB in human inflamed synovial tissue. Arthritis Rheum 1996;39:583–591.